Table II.
Previous cancer among amyotrophic lateral sclerosis (ALS) patients and their birth year and sex matched controls, a nested case-control study in Sweden, 1987–2009a
| Controls (n=27405) | ALS cases (n=5481) | |
|---|---|---|
| No cancer, n (%) | 24635 (89.9) | 4926 (89.9) |
| Any cancer, n (%) | 2770 (10.1) | 555 (10.1) |
| Oral, n | 52 | 16 |
| Anal, n | 126 | 28 |
| Lung/trachea, n | 43 | 12 |
| Renal, n | 262 | 47 |
| Breast, n | 451 | 81 |
| Prostate, n | 539 | 117 |
| Melanoma, n | 143 | 35 |
| Other skin, n | 139 | 31 |
| Endocrine, n | 81 | 17 |
| Brain, n | 69 | 15 |
| Colon, n | 189 | 39 |
| Lymphoma, n | 103 | 12 |
| Cervix, n | 76 | 16 |
| Corpus, n | 131 | 26 |
| Ovarian, n | 64 | 8 |
| Thyroid, n | 34 | 8 |
| Leukemia, n | 30 | 5 |
| Other, n | 238 | 42 |
a
Only cancers with more than 5 cases among ALS cases presented.